CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
9 results
Search Results
Now showing 1 - 9 of 9
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion(Springer Science and Business Media LLC, 2026-04-15) ;Muyang Cheng ;Yue Yin ;Worrawat Engchuan ;Tracy HeungKathleen Angkustsiri1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Source‐based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome(2024) ;Ruiyang Ge ;Christopher R. K. Ching ;Anne S. Bassett ;Leila KushanKevin M. Antshel<jats:title>Abstract</jats:title><jats:p>22q11.2 deletion syndrome (22q11DS) is the most frequently occurring microdeletion in humans. It is associated with a significant impact on brain structure, including prominent reductions in gray matter volume (GMV), and neuropsychiatric manifestations, including cognitive impairment and psychosis. It is unclear whether GMV alterations in 22q11DS occur according to distinct structural patterns. Then, 783 participants (470 with 22q11DS: 51% females, mean age [SD] 18.2 [9.2]; and 313 typically developing [TD] controls: 46% females, mean age 18.0 [8.6]) from 13 datasets were included in the present study. We segmented structural T1‐weighted brain MRI scans and extracted GMV images, which were then utilized in a novel source‐based morphometry (SBM) pipeline (SS‐Detect) to generate structural brain patterns (SBPs) that capture co‐varying GMV. We investigated the impact of the 22q11.2 deletion, deletion size, intelligence quotient, and psychosis on the SBPs. Seventeen GMV‐SBPs were derived, which provided spatial patterns of GMV covariance associated with a quantitative metric (i.e., loading score) for analysis. Patterns of topographically widespread differences in GMV covariance, including the cerebellum, discriminated individuals with 22q11DS from healthy controls. The spatial extents of the SBPs that revealed disparities between individuals with 22q11DS and controls were consistent with the findings of the univariate voxel‐based morphometry analysis. Larger deletion size was associated with significantly lower GMV in frontal and occipital SBPs; however, history of psychosis did not show a strong relationship with these covariance patterns. 22q11DS is associated with distinct structural abnormalities captured by topographical GMV covariance patterns that include the cerebellum. Findings indicate that structural anomalies in 22q11DS manifest in a nonrandom manner and in distinct covarying anatomical patterns, rather than a diffuse global process. These SBP abnormalities converge with previously reported cortical surface area abnormalities, suggesting disturbances of early neurodevelopment as the most likely underlying mechanism.</jats:p>3Scopus© Citations 6 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age(2023) ;Lindsay R. Freud ;Stephanie Galloway ;T. Blaine Crowley ;Julie MoldenhauerAnn Swillen1Scopus© Citations 9 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS(2023) ;Yingjie Zhao ;Yujue Wang ;Lijie Shi ;Donna M. McDonald-McGinnT. Blaine Crowley<jats:title>Abstract</jats:title><jats:p>Congenital heart disease (CHD) affecting the conotruncal region of the heart, occurs in 40–50% of patients with 22q11.2 deletion syndrome (22q11.2DS). This syndrome is a rare disorder with relative genetic homogeneity that can facilitate identification of genetic modifiers. Haploinsufficiency of <jats:italic>TBX1</jats:italic>, encoding a T-box transcription factor, is one of the main genes responsible for the etiology of the syndrome. We suggest that genetic modifiers of conotruncal defects in patients with 22q11.2DS may be in the <jats:italic>TBX1</jats:italic> gene network. To identify genetic modifiers, we analyzed rare, predicted damaging variants in whole genome sequence of 456 cases with conotruncal defects and 537 controls, with 22q11.2DS. We then performed gene set approaches and identified chromatin regulatory genes as modifiers. Chromatin genes with recurrent damaging variants include <jats:italic>EP400</jats:italic>, <jats:italic>KAT6A</jats:italic>, <jats:italic>KMT2C</jats:italic>, <jats:italic>KMT2D</jats:italic>, <jats:italic>NSD1, CHD7</jats:italic> and <jats:italic>PHF21A</jats:italic>. In total, we identified 37 chromatin regulatory genes, that may increase risk for conotruncal heart defects in 8.5% of 22q11.2DS cases. Many of these genes were identified as risk factors for sporadic CHD in the general population. These genes are co-expressed in cardiac progenitor cells with <jats:italic>TBX1</jats:italic>, suggesting that they may be in the same genetic network. The genes <jats:italic>KAT6A</jats:italic>, <jats:italic>KMT2C</jats:italic>, <jats:italic>CHD7</jats:italic> and <jats:italic>EZH2</jats:italic>, have been previously shown to genetically interact with <jats:italic>TBX1</jats:italic> in mouse models. Our findings indicate that disturbance of chromatin regulatory genes impact the <jats:italic>TBX1</jats:italic> gene network serving as genetic modifiers of 22q11.2DS and sporadic CHD, suggesting that there are some shared mechanisms involving the <jats:italic>TBX1</jats:italic> gene network in the etiology of CHD.</jats:p>Scopus© Citations 4 3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion(2020) ;Isabelle Cleynen ;Worrawat Engchuan ;Matthew S. Hestand ;Tracy HeungAaron M. HollemanScopus© Citations 98 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome(2020) ;Robert W. Davies ;Ania M. Fiksinski ;Elemi J. Breetvelt ;Nigel M. WilliamsStephen R. Hooper8Scopus© Citations 101 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effects of copy number variations on brain structure and risk for psychiatric illness: Large‐scale studies from the<scp>ENIGMA</scp>working groups on<scp>CNVs</scp>(2021) ;Ida E. Sønderby ;Christopher R. K. Ching ;Sophia I. Thomopoulos ;Dennis MeerDaqiang Sun3Scopus© Citations 46 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness(2020) ;Christopher R.K. Ching ;Boris A. Gutman ;Daqiang Sun ;Julio Villalon ReinaAnjanibhargavi RagothamanScopus© Citations 44 8 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects(2020) ;Yingjie Zhao ;Alexander Diacou ;H. Richard Johnston ;Fadi I. MusfeeDonna M. McDonald-McGinnScopus© Citations 53 1